Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease

Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease

<h3>Background</h3><p dir="ltr">Despite decades of intensive research, to date, there is no accepted diagnosis for Parkinson’s disease (PD) based on biochemical analysis of blood or CSF. However, neurodegeneration in the brains of PD patients begins several years before t...

Full description

Saved in:
Bibliographic Details
Main Author: Nour K. Majbour (8809316) (author)
Other Authors: Nishant N. Vaikath (2901785) (author), Karin D. van Dijk (18891685) (author), Mustafa T. Ardah (4858657) (author), Shiji Varghese (291775) (author), Louise B. Vesterager (19738231) (author), Liliana P. Montezinho (19738234) (author), Stephen Poole (607442) (author), Bared Safieh-Garabedian (3554684) (author), Takahiko Tokuda (105837) (author), Charlotte E. Teunissen (7830647) (author), Henk W. Berendse (8809328) (author), Wilma D. J. van de Berg (8809325) (author), Omar M. A. El-Agnaf (8809331) (author)
Published: 2016
Subjects:
Biomedical and clinical sciences
Neurosciences
Parkinson’s disease
Alpha synuclein
Cerebrospinal fluid biomarkers
Amyloid oligomers
Biomarkers
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items